DENVER, CO--(Marketwire - Nov 26, 2012) - Mirada Medical announced that its XD3 advanced image review and analysis software has been selected by The Johns Hopkins University, Baltimore, Maryland, for implementation in the department of nuclear medicine. Mirada's latest XD3 software provides powerful tools and efficient workflows for quantitative tumor tracking of findings in an unlimited number of studies for all major modalities including CT, MR, CT/PET and MR/PET.
"We are proud to have our XD3 diagnostic software selected by Johns Hopkins University," said Hugh Bettesworth, CEO of Mirada Medical. "The power of XD3 to assess unlimited time points, and multiple modalities at the same time point, helps clinicians to quantify and make sense out of all the available images. We aim to support them in delivering the most comprehensive assessment of patient response to treatment by fully utilizing all of the available data," continued Bettesworth.
About Mirada Medical Ltd
Mirada Medical is a leading international brand in medical imaging. The company develops advanced software applications which help healthcare professionals use medical images more effectively and efficiently to improve cancer care. Mirada's products are used across diagnostic radiology, molecular imaging, radiation oncology, medical oncology, tumor board and elsewhere.
The company specializes in simplifying technically complex image processing tasks, allowing clinicians to more confidently diagnose disease, assess response to treatment and plan radiation therapy or surgical intervention. Mirada's advanced software products are available throughout the world under its own brand, and on an OEM basis through a select number of the world's leading healthcare companies.
Mirada Medical was originally spun out of the University of Oxford. The company's technologies and products continue to be developed by their team of specialists, engineers and world-renowned scientists at Mirada's world headquarters in Oxford, England.
Mirada Medical, RTx, Casemeeting, Caseaccess and XD3 are all trademarks of Mirada Medical Ltd.
Johns Hopkins Mirada Medical release.
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. Source: Mirada Medical, Oxford Centre for Innovation New Road, Oxford OX1 1BY, UK
If you would like to unsubscribe and stop receiving these e-mails click here.